Hi Emma, are you representing as broker? the issue falls within the insurance policy or not. there must be some sort of official action to be done. so everything is on the track.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling